Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

J Clin Pharmacol. 2011 Nov;51(11):1587-91. doi: 10.1177/0091270010387604. Epub 2011 Jan 5.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / pharmacokinetics*
  • Antipsychotic Agents / therapeutic use
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Piperazines / pharmacokinetics*
  • Piperazines / therapeutic use
  • Schizophrenia / drug therapy
  • Schizophrenia / metabolism*
  • Thiazoles / pharmacokinetics*
  • Thiazoles / therapeutic use
  • Young Adult

Substances

  • Antipsychotic Agents
  • Piperazines
  • Thiazoles
  • ziprasidone